Validation of a Making Decision Hybrid (Ecologic and Virtual) Task

NCT ID: NCT06337500

Last Updated: 2025-07-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

180 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-01

Study Completion Date

2026-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to validate a new hybrid (ecological + virtual) decision-making tool. The difference in behavior (risky choices) between the "hybrid" task and the "virtual" task will be evaluated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Volunteers Behavior and Behavior Mechanisms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Iowa Gambling Task - ecologic

The participant performs the card selection task in its ecological version (with real cards).

Group Type EXPERIMENTAL

Survey

Intervention Type OTHER

Participants complete a survey to evaluate their exposure to screens and their assessment of the laboratory task performed

Iowa Gambling Task - virtual

The participant performs the card selection task in its virtual version (computer task).

Group Type ACTIVE_COMPARATOR

Neurophysiological measure (EEG)

Intervention Type DEVICE

Cerebral electric activity recorded with EEG

Survey

Intervention Type OTHER

Participants complete a survey to evaluate their exposure to screens and their assessment of the laboratory task performed

Iowa Gambling Task - hybrid

The participant performs the card selection task thanks to our homemade interface "LAB-Life".

Group Type EXPERIMENTAL

Neurophysiological measure (EEG)

Intervention Type DEVICE

Cerebral electric activity recorded with EEG

Survey

Intervention Type OTHER

Participants complete a survey to evaluate their exposure to screens and their assessment of the laboratory task performed

Game of Dice Task - ecologic

The participant performs the dice-rolling task in its ecological version (with real dices).

Group Type EXPERIMENTAL

Survey

Intervention Type OTHER

Participants complete a survey to evaluate their exposure to screens and their assessment of the laboratory task performed

Game of Dice Task - virtual

The participant performs the dice-rolling task in its virtual version (computer task)

Group Type ACTIVE_COMPARATOR

Neurophysiological measure (EEG)

Intervention Type DEVICE

Cerebral electric activity recorded with EEG

Survey

Intervention Type OTHER

Participants complete a survey to evaluate their exposure to screens and their assessment of the laboratory task performed

Game of Dice Task - hybrid

The participant performs the dice-rolling task thanks to our homemade interface "LAB-Life".

Group Type EXPERIMENTAL

Neurophysiological measure (EEG)

Intervention Type DEVICE

Cerebral electric activity recorded with EEG

Survey

Intervention Type OTHER

Participants complete a survey to evaluate their exposure to screens and their assessment of the laboratory task performed

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Neurophysiological measure (EEG)

Cerebral electric activity recorded with EEG

Intervention Type DEVICE

Survey

Participants complete a survey to evaluate their exposure to screens and their assessment of the laboratory task performed

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women aged 18 to 65 inclusive
* Subjects with no neurological or psychiatric disorders
* Subjects with no addictive disorder except tobacco
* Signed informed consent indicating that the subject has understood the purpose and procedures of the study and agrees to participate in the study and to abide by the requirements and restrictions inherent in the study
* Affiliation with a French social security scheme or beneficiary of such a scheme.

Exclusion Criteria

* Men and women under 18 or over 65 years of age
* Subjects suffering from a neurological or psychiatric disorder
* Subjects suffering from an addictive disorder, with the exception of tobacco
* Legal incapacity or limited legal capacity
* Subject unlikely to cooperate with the study and/or poor cooperation anticipated by the investigator
* Subject without health insurance
* Pregnant
* Subject within the exclusion period of another study or on the "national volunteer list".
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de Besancon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Julie GIUSTINIANI, MD

Role: PRINCIPAL_INVESTIGATOR

CHU Besançon

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Besançon

Besançon, Not in US/Canada, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Karine CHARRIERE, PhD

Role: CONTACT

+333 81218999

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Karine Charrière

Role: primary

+33381218999

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023/764

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.